Publicação Contínua
Qualis Capes Quadriênio 2017-2020 - B1 em medicina I, II e III, saúde coletiva
Versão on-line ISSN: 1806-9804
Versão impressa ISSN: 1519-3829

Todo o conteúdo do periódico, exceto onde está identificado, está licenciado sob uma

Licença Creative Commons

ARTIGOS ORIGINAIS


Acesso aberto Revisado por pares
0
Visualização

Prevalence of Streptococcus B in pregnant women with preterm birth and its association with adverse outcomes

Marianna Camilo Rezende1; Thamirys Pereira Rodrigues1; Andressa Paes Medeiros de Freitas1; Karina Souza Lopes1; Edward Araujo Júnior2,3; Alberto Borges Peixoto1,4

DOI: 10.1590/1806-9304202500000182-en e20240182

ABSTRACT

OBJECTIVES: the objective this study was evaluating the prevalence of maternal colonization by Group B beta-hemolytic Streptococcus (GBS) in pregnant women who delivered preterm and its relationship with adverse maternal/perinatal outcomes.
METHODS: we carried out a retrospective cohort study with singleton pregnancies with or without a culture for GBS (vaginal-rectum) who delivered spontaneously <37 weeks of gestation.
RESULTS: the study included 190 pregnant women, 53.1% (101/190) did not undergo culture for GBS and 46.8% (89/101) have done. Among the patients who had a culture, 13.5% (12/89) had positive culture for GBS and 86.5% (77/89) had a negative culture. Pregnant women without GBS culture had higher prevalence of preterm birth (74.3 vs. 59.6%, p=0.031) and lower prevalence of antibiotic prophylaxis (27.7 vs. 56.2%, p<0.001) than pregnant women with GBS culture. Higher prevalence of crystalline penicillin G use was observed in pregnant women with positive culture compared to pregnant women with negative culture for GBS (100 vs. 39%, p<0.0001). There was no significant association between pregnant women with or without a culture for GBS or positive and negative GBS cultures and adverse maternal/perinatal outcomes.
CONCLUSION: No significant association was found between GBS culture or not, GBS positive or negative culture, adequate or inadequate GBS prophylaxis, and the prevalence of adverse maternal/perinatal outcomes.

Keywords: Group B beta-hemolytic Streptococcus, Screening, Preterm delivery, Antibiotic prophylaxis, Adverse maternal/perinatal outcomes


O CONTEÚDO DESTE ARTIGO NÃO ESTÁ DISPONÍVEL PARA ESTE IDIOMA.


Copyright © 2025 Revista Brasileira de Saúde Materno Infantil Todos os direitos reservados.

Desenvolvido por: